205 related articles for article (PubMed ID: 24434410)
21. Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis.
Udomkarnjananun S; Takkavatakarn K; Praditpornsilpa K; Nader C; Eiam-Ong S; Jaber BL; Susantitaphong P
J Nephrol; 2020 Apr; 33(2):343-354. PubMed ID: 31701375
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with long-term antibody production induced by hepatitis B vaccine in patients undergoing hemodialysis: a retrospective cohort study.
Elwell RJ; Neumann M; Bailie GR
Pharmacotherapy; 2003 Dec; 23(12):1558-63. PubMed ID: 14695036
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study.
Misurac JM; VanDeVoorde RG; Kallash M; Iorember FM; Luckritz KE; Rheault MN; Jetton JG; Turman MA; Kapur G; Twombley KE; Hashmat S; Weaver DJ; Leiser JD; Nailescu C
Clin J Am Soc Nephrol; 2017 May; 12(5):772-778. PubMed ID: 28270432
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
Jha R; Lakhtakia S; Jaleel MA; Narayan G; Hemlatha K
Ren Fail; 2001 Sep; 23(5):629-36. PubMed ID: 11725909
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of vaccination results in high-risk patients included in hepatitis B vaccination program.
Köse S; Türken M; Cavdar G; Tatar B; Senger SS
Hum Vaccin; 2010 Nov; 6(11):903-5. PubMed ID: 20980797
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
28. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
[TBL] [Abstract][Full Text] [Related]
29. Incidence and Clinical Predictors of Nonresponse to Hepatitis B Vaccination among Patients Receiving Hemodialysis: Importance of Obesity.
Patel N; Assimon MM; Bruni E; McNutt LA; Mason DL
South Med J; 2015 Sep; 108(9):567-73. PubMed ID: 26332483
[TBL] [Abstract][Full Text] [Related]
30. Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population.
Charest AF; Grand'Maison A; McDougall J; Goldstein MB
Am J Kidney Dis; 2003 Dec; 42(6):1193-9. PubMed ID: 14655191
[TBL] [Abstract][Full Text] [Related]
31. Effect of hepatitis C virus on hemoglobin and hematocrit levels in saudi hemodialysis patients.
Alsaran KA; Sabry AA; Alghareeb AH; Al Sadoon G
Ren Fail; 2009; 31(5):349-54. PubMed ID: 19839833
[TBL] [Abstract][Full Text] [Related]
32. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
[TBL] [Abstract][Full Text] [Related]
33. Effect of high-flux hemodialysis on delayed hepatitis B virus vaccination response in hemodialysis patients.
He Q; Wu F; Zhang P; Chen J
Postgrad Med; 2011 May; 123(3):150-2. PubMed ID: 21566425
[TBL] [Abstract][Full Text] [Related]
34. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.
Charest AF; McDougall J; Goldstein MB
Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting on hepatitis B seroprotection in hemodialysis patients.
Malaki M
Saudi J Kidney Dis Transpl; 2017; 28(3):672-674. PubMed ID: 28540917
[No Abstract] [Full Text] [Related]
36. Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience.
Alsaran K; Sabry A; Molhem A
Ren Fail; 2013; 35(10):1305-9. PubMed ID: 24059964
[TBL] [Abstract][Full Text] [Related]
37. Challenges in containing the burden of hepatitis B infection in dialysis and transplant patients in India.
Potsangbam G; Yadav A; Chandel N; Rathi M; Sharma A; Kohli HS; Gupta KL; Minz M; Sakhuja V; Jha V
Nephrology (Carlton); 2011 May; 16(4):383-8. PubMed ID: 21114569
[TBL] [Abstract][Full Text] [Related]
38. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study.
Duong CM; Olszyna DP; McLaws ML
BMC Public Health; 2015 Feb; 15():192. PubMed ID: 25886623
[TBL] [Abstract][Full Text] [Related]
40. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
